LANSDOWNE PARTNERS (UK) LLP 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-17 2:38 pm Sale |
2020-06-12 | 13D | Summit Therapeutics Inc. SMMT |
LANSDOWNE PARTNERS (UK) LLP | 13,664,880 4.060% |
-4,006,035 (-22.67%) |
Filing |
| 2020-05-15 10:18 am Sale |
2020-05-08 | 13D | Summit Therapeutics Inc. SMMT |
LANSDOWNE PARTNERS (UK) LLP | 17,670,915 5.260% |
-3,472,585 (-16.42%) |
Filing |